Seaport Therapeutics
About:
Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Website: https://seaporttx.com/
Top Investors: General Atlantic, ARCH Venture Partners, Invus, Sofinnova Investments, PureTech Health
Description:
Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Total Funding Amount:
$325M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2024-01-01
Contact Email:
info(AT)seaporttx.com
Founders:
Daphne Zohar, Michael Chen, Steven Paul
Number of Employees:
11-50
Last Funding Date:
2024-10-21
IPO Status:
Private
© 2025 bioDAO.ai